![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|18|27|4244-4257
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.18, Iss.27, 2012-09, pp. : 4244-4257
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-Angiogenic Therapies for Children with Cancer
Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antibody-based antiangiogenic cancer therapy
By Sanz Laura Álvarez-Vallina Luis
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. :